Lisdexamfetamine 40 MG capsule 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FDA8U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,674
Award facts
- Contract value 100% obligated
- $10,673.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,673.79 to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Lisdexamfetamine 40 mg capsules (100-count containers). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 22, 2026. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's parent entity, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 and running through December 31, 2031.
AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC with DLA Troop Support Medical functions as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for lisdexamfetamine—a controlled stimulant medication commonly prescribed for attention deficit hyperactivity disorder—represents a routine pharmaceutical procurement supporting the Defense Health Agency and other federal healthcare programs' medication supply requirements.
Quick answers
Who was awarded contract SPE2DR26FDA8U?
SPE2DR26FDA8U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FDA8U worth?
The government has obligated $10,674 on SPE2DR26FDA8U.
Is contract SPE2DR26FDA8U an order under another contract?
Yes. SPE2DR26FDA8U is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDA8U competed?
The extent of competition for SPE2DR26FDA8U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award